about
Recent Progress in Stem Cell Therapy for Diabetic NephropathyNonimmunologic targets of immunosuppressive agents in podocytesVisualization of cytoskeletal dynamics in podocytes using adenoviral vectors.Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy.Sesquiterpene lactones inhibit advanced oxidation protein product-induced MCP-1 expression in podocytes via an IKK/NF-κB-dependent mechanism.Mutual antagonism of Wilms' tumor 1 and β-catenin dictates podocyte health and disease.Trehalose, an mTOR independent autophagy inducer, alleviates human podocyte injury after puromycin aminonucleoside treatment.Dexamethasone-dependent modulation of cyclic GMP synthesis in podocytes.A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules.Inhibition of TRPC6 by protein kinase C isoforms in cultured human podocytesTransforming Growth Factor β1-induced Apoptosis in Podocytes via the Extracellular Signal-regulated Kinase-Mammalian Target of Rapamycin Complex 1-NADPH Oxidase 4 AxisCurrent concepts of the podocyte in nephrotic syndrome.Endothelin-1 and the kidney--beyond BP.β-Arrestins promote podocyte injury by inhibition of autophagy in diabetic nephropathy.Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease.Drug discovery in focal and segmental glomerulosclerosisCalcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent modelsSilencing of Histone Deacetylase 9 Expression in Podocytes Attenuates Kidney Injury in Diabetic Nephropathy.Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease.Proteinuria in preeclampsia from a podocyte injury perspective.Renin-angiotensin system within the diabetic podocyte.The importance of podocyte adhesion for a healthy glomerulus.Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes.From Glomerular Endothelium to Podocyte Pathobiology in Preeclampsia: a Paradigm Shift.Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug development.Overexpression of Myo1e in mouse podocytes enhances cellular endocytosis, migration, and adhesion.A High-Content Screening Technology for Quantitatively Studying Podocyte Dynamics.The podocyte cytoskeleton in health and in disease.Astragaloside IV protects against podocyte injury via SERCA2-dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy.Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic NephropathySirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.Anti-Inflammatory Role of MicroRNA-146a in the Pathogenesis of Diabetic Nephropathy.Human podocytes express functional thermosensitive TRPV channels.Chrysin ameliorates podocyte injury and slit diaphragm protein loss via inhibition of the PERK-eIF2α-ATF-CHOP pathway in diabetic mice.Levamisole in steroid-sensitive nephrotic syndrome: usefulness in adult patients and laboratory insights into mechanisms of action via direct action on the kidney podocyte.Understanding Podocyte Biology to Develop Novel Kidney Therapeutics
P2860
Q26740433-9D5AE7C9-127B-45EA-A4C3-9658DE240E75Q26781358-21E13CF1-5CB9-47D3-9556-56B5D48B35FEQ34361995-E1D59D55-1278-4EA4-B6B9-AE532E032D5DQ34566167-57646E64-6AFF-400A-B3CB-1559D6C1695FQ35022648-D41AB7B7-907D-4730-8641-0B17F132E4E7Q35124213-73F5296C-FF7E-4E4F-91B4-6BBF62657B1CQ35439721-AA2723AB-C433-4B57-9633-CE985295CBA9Q36109237-3A4A0795-93F6-4FC5-98D8-C879B7B3EC6EQ36223325-812DE19E-5CDE-4839-AB8F-7028724AE560Q36394692-976E1394-6A5E-481E-8B69-567326DFF76FQ36407247-E8DD0549-3361-4692-818C-4FE94CF63F56Q36468648-A4AA33E9-A738-4225-B80A-8FE6E235946AQ36619734-87506DFF-AFB9-4318-A230-1B6AD3338322Q36866465-8AEB30A2-8DA3-4489-909B-E2258CE687F3Q36908181-90FB5451-C636-4CE8-8C93-AC14CF865177Q36924116-7CCBA2EE-CA88-493A-BE37-743EB50B1B26Q37223452-C62BF902-F054-4E17-8DF8-0A83659D97B7Q37260645-F6B5B527-1CBA-4356-BFAC-D2D9CFAFDA14Q38097111-55B100EE-3A36-4196-8640-8C04580CB15DQ38161490-3B5DF2B2-14FF-42A4-87BE-7B2C56930C85Q38262105-2F23638C-7448-4957-A35E-306509DD90CEQ38263509-1C8AB24A-AF66-42C2-81DA-AA2098B0F78AQ38395906-563F551D-EDCB-4591-8EE4-77D234DA72DDQ38525974-16A34411-BCDF-467C-B58A-006EEA9A4073Q38988798-55A8B1E3-B7C6-4784-AC69-4100F6E27726Q39043104-64B8E450-BF2E-4F08-973C-EA27000DCFB8Q39303932-20DF66C5-1387-4486-88AC-6337579C6DA9Q39721946-3FF4B710-22B6-4CCD-B8B0-414D8C4F16DDQ41192324-F8BB69EC-E066-4445-A29E-4E3965FB22E7Q41574426-53D31802-6831-4952-A77E-B16CE71C0415Q41605771-857FA65B-243D-414B-AB85-0B61BB885B38Q42371220-A82E450E-E7FE-4E43-8A73-3C16CEDCDE81Q47747291-73BB3AD1-1734-4796-9AE9-2C4886DF839BQ51002474-5DFADDC9-271B-4CE2-9DCB-90F0AEF4E00BQ53634292-ECCE93F6-2899-43F9-A100-23035C4F7A24Q57175033-897636B1-4161-45D1-8A53-0303F3C35791
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The podocyte as a target for therapies--new and old.
@en
The podocyte as a target for therapies--new and old.
@nl
type
label
The podocyte as a target for therapies--new and old.
@en
The podocyte as a target for therapies--new and old.
@nl
prefLabel
The podocyte as a target for therapies--new and old.
@en
The podocyte as a target for therapies--new and old.
@nl
P2860
P356
P1476
The podocyte as a target for therapies--new and old.
@en
P2093
Peter W Mathieson
P2860
P2888
P356
10.1038/NRNEPH.2011.171
P407
P577
2011-11-01T00:00:00Z